Authors: Bagnato, F Pietropoaolo, V Di Taranto, C Lorenzano, S Toni, D

Citation: F. Bagnato et al., Chronic lymphocytic leukemia complicated by progressive multifocal leukoencephalopathy withouth apparent immunodepression, EUR J NEUR, 8(4), 2001, pp. 367-368

Authors: Sormani, MP Rovaris, M Bagnato, F Molyneux, P Bruzzi, P Pozzilli, C Miller, DH Comi, G Filippi, M

Citation: Mp. Sormani et al., Sample size estimations for MRI-monitored trials of MS comparing new vs standard treatments, NEUROLOGY, 57(10), 2001, pp. 1883-1885

Authors: Ciccarelli, O Bagnato, F Mainero, C Salvetti, M Paolillo, A Gasperini, C Bastianello, S Pozzilli, C

Citation: O. Ciccarelli et al., Antinuclear antibodies and response to IFN beta-1a therapy in relapsing-remitting multiple sclerosis, MULT SCLER, 6(3), 2000, pp. 137-139

Authors: Bagnato, F Tancredi, A Richert, N Gasperini, C Bastianello, S Bash, C McFarland, H Pozzilli, C Frank, JA

Citation: F. Bagnato et al., Contrast-enhanced magnetic resonance activity in relapsing remitting multiple sclerosis patients: a short term natural history study, MULT SCLER, 6(1), 2000, pp. 43-49

Authors: Antonelli, G Simeoni, E Bagnato, F Pozzilli, C Turriziani, O Tesoro, R Di Marco, P Gasperini, C Fieschi, C Dianzani, F

Citation: G. Antonelli et al., Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b, J NEUR SCI, 168(2), 1999, pp. 131-136